Meeting China's NMPA requirements
Driven by its massive population and growing economy, China’s healthcare market is one of the most lucrative in the world and presents significant opportunities. However, understanding the regulatory landscape is critical and medical device manufacturers seeking market access must overcome notable challenges.
The NMPA has taken several steps to reduce the burden on certain products and make this process more accessible, including:
Implementing several regulatory reforms to streamline processes and encourage innovation
Expanded the list of devices exempt from clinical evaluation requirements
Introduced a green channel to expedite pre-market review, offering qualifying devices a faster route
Medical Device Regulations in China: Meeting NMPA requirements
1.77 MB
To download our white paper, please fill out the form below:
This Emergo by UL white paper answers your top questions and outlines the medical device regulations in China to help you prepare to meet NMPA requirements.
Please wait…